PHARMACEUTICAL COMPOSITION COMPRISING THIACREMONONE FOR PREVENTING OR TREATING CANCER
申请人:Hong Jin Tae
公开号:US20090093536A1
公开(公告)日:2009-04-09
The present invention relates to an anti-cancer composition, which comprises a sulfur-containing compound thiacremonone as an active ingredient. The active ingredient induces the death of cancer cells by apoptosis through the action of specific inhibition of the activity of NF-κB. The composition can be effectively used in the treatment or prevention of cancer.
US7759391B2
申请人:——
公开号:US7759391B2
公开(公告)日:2010-07-20
Isolation, identification, and formation conditions of a novel Maillard yellowish pigment, pyrrolothiazolate
作者:Kyoko Noda、Shinji Yamada、Masatsune Murata
DOI:10.1080/09168451.2015.1018127
日期:2015.8.3
Pyrrolothiazolate formed from cysteine and glucose was the major low-molecular-weight Maillard pigment in the reaction mixture, and its formation was stimulated by adding lysine to the reaction cocktail. After heating at 110 °C for 2 h, 1-2 mg/mL of pyrrolothiazolate was formed in a reaction mixture containing 100 mM cysteine, 200 mM lysine, and 300 mM glucose dissolved in 0.5 m acetate buffer (pH 6.0) or 0.5 m